Test Price
450 AEDโ Home Collection Available
Female Infertility Comprehensive Panel in UAE | 450 AED | DNA Labs UAE
Executive Summary & Core Metrics
The Female Infertility Comprehensive Panel provides a diagnostic sensitivity of 99.9% through ISO 9001:2015 accredited processing at a DHA-licensed laboratory. Our service includes VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (daily 8 AM โ 11 PM), telephonic post-test clinical guidance by a DHA-licensed physician, and direct billing verification via WhatsApp.
- โ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- โ Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AM โ 11 PM).
- โ Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by a DHA-licensed physician.
- โ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Female Infertility Comprehensive Panel is a multi-analyte serum investigation measuring key reproductive and endocrine hormones (FSH, LH, Estradiol, Prolactin, TSH, AMH) using standardized immunoassay techniques. It is the first-line laboratory triage for menstrual irregularities, ovarian reserve assessment, and unexplained infertility in women of reproductive age.
| Feature | Our Test (ISO 9001:2015) | Closest Alternative |
|---|---|---|
| Precision & Methodology | Chemiluminescent Immunoassay (CLIA) & ELISA โ traceable to WHO International Standards | Conventional ELISA only; higher inter-laboratory CV |
| Turnaround Time | Same-day report (sample by 9 AM) | 2โ5 working days |
| Pre-analytical Compliance | Strict adherence to DHA/MOHAP sample collection protocol (Day 2/3, fasting) | Variable; no cycle-specific guidance |
Physician Insight & Safety Protocols
โThis panel offers a foundational hormonal snapshot, but never rely on a single value in isolation. The timing of collectionโstrictly cycle day 2 or 3โis critical for interpretability. Always correlate results with clinical history, imaging, and a dialogue with your gynecologist or endocrinologist.โ
โ Dr. Ajay Singh, DHA License No. 36234132 (General Practitioner)
Advisory: Medication Precautions
Do not discontinue prescribed medication, especially thyroid hormones, insulin, or fertility drugs, without consulting your doctor. Abrupt cessation can cause endocrine destabilisation and may confound the interpretation of your results.
Exclusion Criteria & Emergency Red Flags
- Active acute illness or febrile condition within the last 48 hours โ reschedule collection.
- Recent (within 6 weeks) hormonal contraception change, emergency contraception, or injectable progestin use (may invalidate baseline values).
- Known haemodynamic instability, severe anaemia, or uncontrolled thyroid storm โ proceed directly to emergency care, not routine phlebotomy.
- If you experience sudden severe pelvic pain, vision changes, or galactorrhoea, seek urgent medical attention before relying on this test.
Patient FAQ & Clinical Guidance
1. Why must the blood sample be taken on Day 2 or 3 of my menstrual cycle?
Collecting a blood sample on cycle Day 2 or 3 provides a baseline hormonal profile when ovarian follicles are quiescent, allowing precise assessment of FSH, LH, and estradiol without the influence of a developing dominant follicle.
2. What does an elevated FSH level indicate, and should I be worried?
An elevated follicle-stimulating hormone level on Day 2/3 often suggests diminished ovarian reserve or primary ovarian insufficiency, but it must be interpreted together with your age, AMH level, and antral follicle count โ a single value is not a sole predictor of fertility potential.
3. How soon after the test can I discuss the results with a specialist?
You will receive a same-day report, and you can book a telephonic clinical guidance session with a DHA-licensed specialist within 24 hours to correlate the findings with your personal fertility journey, ensuring immediate, actionable next steps.
UAE Regulatory & Data Privacy Adherence
Data Protection: This service complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed under Federal Decree-Law No. 4 of 2016 on Medical Liability. Your personal and health data are processed solely for diagnostic purposes and are never shared without explicit consent.
Laboratory Accreditation: ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | DHA Facility License: 1143
Address: Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE
Clinical & Logistical Metadata
| Test Name | Female Infertility Comprehensive Panel |
| Price (AED) | 450 |
| Turnaround Time | Same-day report (sample by 9 AM) |
| Sample Type / Matrix | Serum (peripheral blood) |
| Methodology Used | Chemiluminescent Immunoassay (CLIA) & ELISA |
| ICD-10-CM Code | N97.9 (Female infertility, unspecified) |
| LOINC Code | 24336-0 (Hormone panel - Female) |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians